S. Salvin

发表

BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands.

M. Isola, L. Quartuccio, S. De Vita, 2013, Rheumatology.

Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.

S. Bombardieri, M. Isola, R. Priori, 2014, Journal of autoimmunity.

Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy.

L. Quartuccio, S. De Vita, C. Scott, 2014, Clinical and experimental rheumatology.

Efficacy and safety of belimumab given for 12 months in primary Sjögren's syndrome: the BELISS open-label phase II study.

P. Ravaud, X. Mariette, M. Isola, 2015, Rheumatology.

Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study.

G. Baron, P. Ravaud, X. Mariette, 2015, Annals of the rheumatic diseases.

Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study

S. Bombardieri, M. Isola, R. Priori, 2015, Scandinavian journal of rheumatology.

Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study.

S. Gandolfo, L. Quartuccio, S. De Vita, 2016, Clinical and experimental rheumatology.

THU0392 Efficacy and Safety of Belimumab Given for 12 Months in Primary sjögren's Syndrome: The Beliss Open-Label Phase II Study

P. Ravaud, X. Mariette, M. Isola, 2015 .

Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia

C. Baldini, L. Quartuccio, S. De Vita, 2007, Annals of the rheumatic diseases.

Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy.

L. Quartuccio, S. De Vita, A. Zabotti, 2012, Rheumatology.

High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren's syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type.

M. Ponzoni, L. Quartuccio, S. De Vita, 2014, Clinical and experimental rheumatology.

THU0188 Lymphoproliferative complications in the course of primary sjægren’s syndrome: Prevalence and common features in a large cohort of patients

S. Bombardieri, M. Isola, R. Priori, 2013 .

The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study

S. Bombardieri, P. Sarzi-Puttini, R. Caporali, 2013, Annals of the rheumatic diseases.

Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis.

M. Cutolo, F. Atzeni, M. Benucci, 2010, Rheumatology.

Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy

L. Quartuccio, S. De Vita, S. Sacco, 2008, Annals of the rheumatic diseases.

[Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes].

S. Bombardieri, L. Quartuccio, S. De Vita, 2011, Reumatismo.

FRI0255 The 158vv fcgamma receptor 3a genotype is associated with response to rituximab in rheumatoid arthritis: results of an italian multicentre study

S. Bombardieri, R. Caporali, G. Paolazzi, 2013 .

Controversies on Rituximab Therapy in Sjögren Syndrome-Associated Lymphoproliferation

L. Quartuccio, S. De Vita, M. Fabris, 2010, International journal of rheumatology.

Pharmacological Properties of CY 216 and of Its ACLM and BCLM Components in the Rabbit

G. Houin, B. Boneu, S. Salvin, 1994, Thrombosis and Haemostasis.

Cost saving and predictive factors of response to rituximab in rheumatoid arthritis, including the IL-6 promoter gene polymorphism

M. Benucci, L. Quartuccio, G. Guarrera, 2012 .

Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands.

L. Quartuccio, S. De Vita, A. Zabotti, 2016, Clinical and experimental rheumatology.

Pleuritis is a red flag for adult-onset Still's disease which may require biologic therapies.

L. Quartuccio, S. De Vita, S. Salvin, 2012, Clinical and Experimental Rheumatology.

Bone marrow B-cell clonal expansion in type II mixed cryoglobulinaemia: association with nephritis.

C. Beltrami, M. Isola, E. Falleti, 2007, Rheumatology.